Compare

Ducommun/$DCO

1D1W1M3M6MYTD1Y5YMAX

About Ducommun

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers, and manufactures various sizes of complex contoured aerostructure components and assemblies, and supplies composite and metal-bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets, including A&D and Industrial end-use markets. It generates a maximum of its revenue from the Electronic Systems.
Ticker
$DCO
Primary listing
NYSE
Employees
2,130

Ducommun Metrics

BasicAdvanced
$2B
38.94
$3.47
1.09
-

What the Analysts think about Ducommun

Analyst ratings (Buy, Hold, Sell) for Ducommun stock.
Analyst projections of the future price of Ducommun stock.

Bulls say / Bears say

Defense orders are building into a sizeable revenue base: remaining performance obligations hit a record $1.3 billion, and defence bookings had a 2.2x book-to-bill ratio in Q3. That supports management’s expectation of stronger defence momentum in 2027. (Ducommun Incorporated)
Commercial aerospace is recovering, with Q3 revenue up 28% year on year on stronger Boeing 737 MAX and Airbus A320 activity, nearing a $100 million quarterly run rate. Higher aircraft production could provide another leg of growth. (Ducommun Incorporated)
Profitability is improving: gross margin reached a record 28.9%, while adjusted EBITDA margin rose to 17.5%, close to the company’s 18% 2027 goal. Its longer-term plan targets a 23% adjusted EBITDA margin, supported by a higher mix of engineered products. (Ducommun Incorporated, Ducommun Incorporated)
Revenue conversion remains uneven despite strong total bookings: military and space sales fell $9.2 million in Q3 as production eased on selected programmes, while commercial aerospace bookings were below shipments, with a 0.8x book-to-bill ratio. Delays or shifts in customer orders could therefore make growth lumpy. (Ducommun Incorporated)
The company’s recent filings flag a material weakness in financial reporting controls and restatements of prior-year results. That leaves investors with continuing reporting and governance risk even as current margins improve. (U.S. Securities and Exchange Commission)
A valuation-sensitive investor may see less room for upside: RBC downgraded the shares, arguing that much of the near-term benefit from defence exposure was already reflected in the price. If expected growth disappoints, that could leave the shares vulnerable to a reset. (Seeking Alpha)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.

Ducommun Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Ducommun Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Ducommun

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.